Table 2.
Age | |
Median | 70 years |
Range | 49–86 years |
PSA | |
Median | 13.7 ng/ml |
Range | 1.0–919.6 ng/ml |
Androgen dependent | 12/41 (29%) |
Androgen independent | 29/41 (71%) |
Metastases | 16/41 (39%) |
Bidimensionally measurable disease | 0/41 (0%) |
Gleason sum | |
4–6 | 4/41 (11%) |
7 | 14/41 (34%) |
8–10 | 23/41 (55%) |